{
    "clinical_study": {
        "@rank": "98982", 
        "arm_group": [
            {
                "arm_group_label": "Olodaterol andTiotropium", 
                "arm_group_type": "Experimental", 
                "description": "2 puffs Olodaterol from Respimat and one capsule Tiotropium by Handihaler once daily in am, co-administered"
            }, 
            {
                "arm_group_label": "Placebo and Tiotropium", 
                "arm_group_type": "Other", 
                "description": "2 puffs placebo inhalation solution from Respimat and one capsule Tiotropium by Handihaler once daily in am, co-administered"
            }
        ], 
        "brief_summary": {
            "textblock": "The overall objective of this study is to assess efficacy and safety of 12 weeks, once\n      daily, orally inhaled co-administration of olodaterol 5 \u00b5g (delivered by the Respimat\u00ae\n      Inhaler) and tiotropium (delivered by the Handihaler\u00ae as Spiriva Handihaler\u00ae), compared to\n      tiotropium (Spiriva Handihaler\u00ae) monotherapy on lung function in patients with COPD."
        }, 
        "brief_title": "Co-administration of Olodaterol Respimat\u00ae andTtiotropium Handihaler\u00ae", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pulmonary Disease, Chronic Obstructive", 
        "condition_browse": {
            "mesh_term": [
                "Chronic Disease", 
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. All patients must sign an informed consent consistent with International Conference\n             on Harmonization-Good Clinical Practice (ICH-GCP) guidelines prior to participation\n             in the trial, which includes medication washout and restrictions.\n\n          2. All patients must have a diagnosis of chronic obstructive pulmonary disease and must\n             meet the following spirometric criteria: Patients must have a relatively stable\n             airway obstruction with a post-bronchodilator FEV1  = 30 % and < 80% of predicted\n             normal and a post-bronchodilator FEV1/FVC <70% at Visit 1.\n\n          3. Male or female patients, 40 years of age or older.\n\n          4. Patients must be current or ex-smokers with a smoking history of more than 10 pack\n             years\n\n          5. Patients must be able to: perform technically acceptable pulmonary function tests,\n             and maintain records(paper diary).\n\n          6. Patients must be able to inhale medication in a competent manner from the Respimat\n             Inhaler as well as the Handihaler.\n\n        Exclusion criteria:\n\n          1. Patients with a significant disease other than COPD; a significant disease is defined\n             as a disease which, in the opinion of the investigator, may (i) put the patient at\n             risk because of participation in the study, (ii) influence the results of the study,\n             or (iii) cause concern regarding the patients ability to participate in the study.\n\n          2. Patients with clinically relevant abnormal baseline haematology, blood chemistry, or\n             urinalysis; all patients with an AST >x2 ULN, ALT >x2 ULN, bilirubin >x2 ULN or\n             creatinine >x2 ULN will be excluded regardless of clinical condition (a repeat\n             laboratory evaluation will not be conducted in these patients).\n\n          3. Patients with a history of asthma. For patients with allergic rhinitis or atopy,\n             source documentation is required to verify that the patient does not have asthma. If\n             a patient has a total blood eosinophil count =600/mm3, source documentation is\n             required to verify that the increased eosinophil count is related to a non-asthmatic\n             condition.\n\n          4. A diagnosis of thyrotoxicosis (due to the known class side effect profile of\n             \u00df2-agonists).\n\n          5. A diagnosis of paroxysmal tachycardia (>100 beats per minute) (due to the known class\n             side effect profile of \u00df2-agonists).\n\n          6. A history of myocardial infarction within 1 year of screening visit (Visit 1).\n\n          7. Unstable or life-threatening cardiac arrhythmia.\n\n          8. Hospitalization for heart failure within the past year.\n\n          9. Known active tuberculosis.\n\n         10. A malignancy for which patient has undergone resection, radiation therapy or\n             chemotherapy within last five years (patients with treated basal cell carcinoma are\n             allowed).\n\n         11. A history of life-threatening pulmonary obstruction.\n\n         12. A history of cystic fibrosis.\n\n         13. Clinically evident bronchiectasis.\n\n         14. A history of significant alcohol or drug abuse.\n\n         15. Patients who have undergone thoracotomy with pulmonary resection (patients with a\n             history of thoracotomy for other reasons should be evaluated as per exclusion\n             criterion No. 1).\n\n         16. Patients being treated with oral or patch \u00df-adrenergics.\n\n         17. Patients being treated with oral corticosteroid medication at unstable doses (i.e.,\n             less than six weeks on a stable dose) or at doses in excess of the equivalent of 10\n             mg of prednisone per day or 20 mg every other day.\n\n         18. Patients who regularly use daytime oxygen therapy for more than one hour per day and\n             in the investigators opinion will be unable to abstain from the use of oxygen therapy\n             during clinic visits.\n\n         19. Patients who have completed a pulmonary rehabilitation program in the six weeks prior\n             to the screening visit (Visit 1) or patients who are currently in a pulmonary\n             rehabilitation program.\n\n         20. Patients who have taken an investigational drug within one month or six half lives\n             (whichever is greater) prior to screening visit (Visit 1).\n\n         21. Patients with known hypersensitivity to \u00df-adrenergic drugs, BAC, EDTA, or any other\n             component of the Respimat\u00ae inhalation solution.\n\n         22. Patients with known hypersensitivity to anticholinergic drugs, lactose, or any other\n             components of the HandiHaler\u00ae.\n\n         23. Pregnant or nursing women.\n\n         24. Women of childbearing potential not using a highly effective method of birth\n             control*. Female patients will be considered to be of childbearing potential unless\n             surgically sterilised by hysterectomy or bilateral tubal ligation, or post-menopausal\n             for at least two years.\n\n             * as per ICH M3(R2)  a highly effective method of birth control is defined as those\n             which result in a low failure rate (i.e. less than 1% per year).\n\n         25. Patients who have previously been randomised in this study or are currently\n             participating in another study.\n\n         26. Patients who are unable to comply with pulmonary medication restrictions prior to\n             randomisation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "1137", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01696058", 
            "org_study_id": "1222.52"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo and Tiotropium", 
                "description": "marketed product", 
                "intervention_name": "Tiotropium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo and Tiotropium", 
                "description": "one dose", 
                "intervention_name": "Placebo matching Olodaterol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Olodaterol andTiotropium", 
                "description": "marketed product", 
                "intervention_name": "Tiotropium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Olodaterol andTiotropium", 
                "description": "one dose", 
                "intervention_name": "Olodaterol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tiotropium"
        }, 
        "lastchanged_date": "January 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Anniston", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "1222.52.02090 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "1222.52.02046 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mobile", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "1222.52.02014 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montgomery", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "1222.52.02017 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anchorage", 
                        "country": "United States", 
                        "state": "Alaska"
                    }, 
                    "name": "1222.52.02092 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chandler", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "1222.52.02072 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glendale", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "1222.52.02063 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Peoria", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "1222.52.02088 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona"
                    }, 
                    "name": "1222.52.02012 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huntington Beach", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.52.02006 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Jose", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.52.02031 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "1222.52.02011 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boulder", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "1222.52.02061 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Collins", 
                        "country": "United States", 
                        "state": "Colorado"
                    }, 
                    "name": "1222.52.02054 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hartford", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "1222.52.02001 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norwalk", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "1222.52.02037 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Waterbury", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "1222.52.02055 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clearwater", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.52.02094 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.52.02022 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.52.02074 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ponte Verda", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.52.02016 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersberg", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.52.02084 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "1222.52.02043 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Blue Ridge", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.52.02009 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duluth", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.52.02048 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainsville", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.52.02077 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rincon", 
                        "country": "United States", 
                        "state": "Georgia"
                    }, 
                    "name": "1222.52.02040 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "O'Fallon", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "1222.52.02024 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muncie", 
                        "country": "United States", 
                        "state": "Indiana"
                    }, 
                    "name": "1222.52.02002 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Mitchell", 
                        "country": "United States", 
                        "state": "Kentucky"
                    }, 
                    "name": "1222.52.02008 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky"
                    }, 
                    "name": "1222.52.02025 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "1222.52.02089 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "1222.52.02005 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbia", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "1222.52.02029 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hollywood", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "1222.52.02036 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Townson", 
                        "country": "United States", 
                        "state": "Maryland"
                    }, 
                    "name": "1222.52.02015 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Dartmouth", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }, 
                    "name": "1222.52.02034 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chelsea", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "1222.52.02003 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kalamazoo", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "1222.52.02020 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "1222.52.02047 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "1222.52.02049 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plymouth", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "1222.52.02079 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chesterfield", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "1222.52.02068 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "1222.52.02028 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "1222.52.02053 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Billings", 
                        "country": "United States", 
                        "state": "Montana"
                    }, 
                    "name": "1222.52.02050 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Henderson", 
                        "country": "United States", 
                        "state": "Nevada"
                    }, 
                    "name": "1222.52.02035 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marlton", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "1222.52.02030 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albuquerque", 
                        "country": "United States", 
                        "state": "New Mexico"
                    }, 
                    "name": "1222.52.02071 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Johnson City", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "1222.52.02064 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Windsor", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "1222.52.02087 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Syracuse", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "1222.52.02091 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Calabash", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.52.02076 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huntersville", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.52.02010 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.52.02045 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salisbury", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.52.02038 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shelby", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.52.02051 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tabor City", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.52.02058 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winston Salem", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }, 
                    "name": "1222.52.02013 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.52.02062 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.52.02039 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.52.02081 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio"
                    }, 
                    "name": "1222.52.02093 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }, 
                    "name": "1222.52.02059 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medford", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "1222.52.02026 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Medford", 
                        "country": "United States", 
                        "state": "Oregon"
                    }, 
                    "name": "1222.52.02097 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "1222.52.02075 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "1222.52.02102 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "1222.52.02080 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02100 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Easley", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02096 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02085 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02101 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hodges", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02065 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Myrtle Beach", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02042 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rock Hill", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02083 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spartanburg", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02095 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spartanburg", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02066 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Union", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "1222.52.02098 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brentwood", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "1222.52.02018 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Arlington", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02086 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02044 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "El Paso", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02041 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Worth", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02027 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02056 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02007 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02060 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sugar Land", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02078 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Waco", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "1222.52.02082 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Midvale", 
                        "country": "United States", 
                        "state": "Utah"
                    }, 
                    "name": "1222.52.02057 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "1222.52.02023 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Selah", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "1222.52.02069 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tacoma", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "1222.52.02019 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Morgantown", 
                        "country": "United States", 
                        "state": "West Virginia"
                    }, 
                    "name": "1222.52.02099 Boehringer Ingelheim Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of 12 Weeks of Once Daily, Orally Inhaled, Co-administration of Olodaterol 5\u00b5g (Delivered by the Respimat\u00ae Inhaler) and Tiotropium 18\u00b5g (Delivered by the HandiHaler\u00ae) Compared to Once Daily, Orally Inhaled, Co-administration of Placebo (Delivered by the Respimat\u00ae Inhaler) and Tiotropium 18\u00b5g (Delivered by the HandiHaler\u00ae) in Patients With Chronic Obstructive Pulmonary Disease (COPD)[ANHELTO TM 2]", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "FEV1 AUC0-3h response at 12 weeks; defined as change from baseline to Week 12", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Trough FEV1 response at 12 weeks; defined as change from baseline to Week 12", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01696058"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Saint George Respiratory Questionnaire-  (Total Score)- Key Secondary endpoint", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Peak FEV1  response at 12 weeks; defined as changes from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "FVC AUC0-3h response at 12 weeks; defined as changes from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 Weeks"
            }, 
            {
                "measure": "Peak  FVC response at 12 weeks; defined as changes from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Trough FVC response at 12 weeks; defined as changes from baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Rescue medication usage - two variables will be calculated for each patient; the number of rescue free days, and weekly mean use of rescue medications", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}